© 2020 MJH Life Sciences and HCPLive. All rights reserved.
Geriatrics
FDA Sets PDUFA Date on Aducanumab for Alzheimer Disease
August 07, 2020
Article
Investigators found a 22% reduction in clinical decline at the 78-week cutoff in the intent to treat population in EMERGE who received high-dose aducanumab, with a similar reduction seen in the opportunity to complete population.
COVID-19 Exposes Geriatric Telemedicine Unreadiness
August 06, 2020
Article
A new study has great implications for equitable access to primary care for older adults during the pandemic.
Dementia-Related Psychosis a Burden for Both Patients and Caretakers
August 06, 2020
Article
In a pair of studies, 42% of patients and care partners reported having no current treatment.
Study Warrants Screening for Both Eyes in DME Patients
July 29, 2020
Article
An interview with a Cleveland Clinic investigator on adjusting macular edema screening methods.
How Ophthalmology Has Evolved During COVID-19
July 29, 2020
Video
A perspective on what's moved virtually, and what hasn't, since the pandemic began in March.
Anti-VEGF Injections Associated with Cognitive Impairment in AMD Patients
July 28, 2020
Article
Interim findings from a cross-sectional study shows a correlation between worse cognitive scoring and a greater rate of intravitreal injections.
Anti-VEGF Treat-and-Extend Regimen Benefits nAMD through Six Years
July 27, 2020
Article
A new analysis of a trio of intravitreal agents show maintained visual acuity in treatment-naive patients for at least 5 years.
Improving Ophthalmology Screening and Telemedicine
July 27, 2020
Video
The specialty is on the precipice of advancement. What gets it over the hurdle?
Mixed Results in Ongoing Brolucizumab Study for nAMD
July 27, 2020
Article
A large proportion of nAMD patients treated with anti-VEGF therapies continue to have active disease and fluid.
What Is the Cross-Specialty Collaboration for Retina Disease?
July 26, 2020
Video
A look at how the specialty functions in telemedicine, and how it could work better with primary care physicians and endocrinologists.